» Articles » PMID: 36699435

A First Clinical and Molecular Study of Rare IVS-II-806 (G > C) (HBB:c.316-45G > C) Variant in the β-globin Gene: A Possibly Benign Variant

Overview
Specialty Hematology
Date 2023 Jan 26
PMID 36699435
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: β-thalassemia is a common genetic disease affecting a single gene, disease with a high incidence in South China. We hereby, aim to provide the clinical and hematological features of a rare β-globin gene variant in the Chinese population.

Methods: Ten subjects from three unrelated Chinese families were enrolled in this study. Hematological analysis and thalassemia gene testing were preformed to screen for common α and β-thalassemia variants. Gap-polymerase chain reaction (Gap-PCR) and DNA sequencing were utilized to examine the rare or novel thalassemia variants.

Results: Six cases were identified carrying the rare IVS-II-806 (G > C) (HBB:c.316-45G > C) variant in the β-globin gene. The proband in family 1 carry three rare β-globin gene mutations including CD39 (C > T), IVS-II-81 (C > T) and IVS-II-806 (G > C) combined with a --/αα deletion, exhibiting the β-thalassemia trait. Further pedigree investigation indicated that the genotype of the proband in family 1 was --/αα, β/β. Meanwhile, the twin girls in family 1 carrying the IVS-II-806 (G > C) mutation demonstrated a normal hematological phenotype. In family 2, the proband and his sister carry the IVS-II-806 (G > C) mutation, eliciting high levels of Hb A2 and slightly low levels of MCV and MCH. Moreover, the proband in family 3 carrying the same mutation exhibited a slightly low MCV level as well.

Conclusions: In this study, clinical and hematological analysis of the IVS-II-806 (G > C) mutation was first conducted within the Chinese population, with results indicating that it may be a benign variant.

Citing Articles

Molecular characterization of similar Hb Lepore Boston-Washington in four Chinese families using third generation sequencing.

Zhuang J, Zhang N, Zheng Y, Jiang Y, Chen Y, Mao A Sci Rep. 2024; 14(1):9966.

PMID: 38693200 PMC: 11063182. DOI: 10.1038/s41598-024-60604-7.

References
1.
Silva A, Cardoso G, Cunha D, Diniz I, Santos S, Andrade G . The Spectrum of β-Thalassemia Mutations in a Population from the Brazilian Amazon. Hemoglobin. 2015; 40(1):20-4. DOI: 10.3109/03630269.2015.1083443. View

2.
Taher A, Weatherall D, Cappellini M . Thalassaemia. Lancet. 2017; 391(10116):155-167. DOI: 10.1016/S0140-6736(17)31822-6. View

3.
Zhuang J, Zheng Y, Wang Y, Zhuang Q, Jiang Y, Xie Q . Identification of a new β-thalassaemia variant Term CD+32(HBB: c.32A>C) in two Chinese families. J Clin Pathol. 2020; 73(9):593-596. DOI: 10.1136/jclinpath-2020-206426. View

4.
Kazazian Jr H, Boehm C . Molecular basis and prenatal diagnosis of beta-thalassemia. Blood. 1988; 72(4):1107-16. View

5.
Lopez-Escribano H, Parera M, Guix P, Serra J, Gutierrez A, Balsells D . Balearic archipelago: three islands, three beta-thalassemia population patterns. Clin Genet. 2012; 83(2):175-80. DOI: 10.1111/j.1399-0004.2012.01864.x. View